The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ADAPY · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | ADAPY | NMTC | XBIT | SLN |
|---|---|---|---|---|
| Moat Score (0–100) | 36 (highest) | 36 (highest) | 36 (highest) | 36 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 66 | 70 (highest) | 0 | 27 |
| Pricing power | — | 13 | 70 | 75 (highest) |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital discipline | 24 | 44 | 57 (highest) | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $50.7M | $108.0M | $68.6M | $1.5B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2024 | FY2025 | FY2025 | FY2025 |